Leveraging genomic signatures of oral microbiome-associated antibiotic resistance genes for diagnosing pancreatic cancer
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Researchers explored antibiotic resistance genes (ARGs) in the oral microbiome for pancreatic ductal adenocarcinoma (PDAC) diagnosis. Specific ARGs show potential for non-invasive early detection of PDAC.
Area Of Science
- Microbiology
- Genomics
- Oncology
Background
- The oral microbiome is linked to various diseases, including pancreatic ductal adenocarcinoma (PDAC).
- Gene-level information from the oral microbiome for PDAC diagnosis is underexplored.
- Antibiotic resistance genes (ARGs) represent a novel genomic signature within the oral microbiome.
Purpose Of The Study
- To investigate the diagnostic potential of oral microbiome ARGs for PDAC.
- To identify specific ARGs associated with PDAC presence.
- To evaluate the efficacy of ARGs as non-invasive biomarkers for early PDAC detection.
Main Methods
- Analysis of oral microbiome samples from PDAC patients and healthy controls.
- Sequencing and abundance profiling of antibiotic resistance genes (ARGs).
- Statistical analysis to identify ARGs correlated with PDAC status.
Main Results
- Distinct ARG sequence abundance profiles were identified between PDAC patients and healthy individuals.
- Three ARGs were enriched in the healthy group, while 21 ARGs were enriched in the PDAC group.
- The identified ARGs demonstrated promising diagnostic capability for PDAC with an AUROC of 0.79.
Conclusions
- Oral microbiome ARGs can serve as potential biomarkers for PDAC diagnosis.
- This approach offers a non-invasive method for early detection of pancreatic cancer.
- Findings highlight the complex relationship between oral microbiota and PDAC development.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.